Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma
口服 ENMD-2076 治疗晚期纤维板层癌患者的 II 期多中心、开放标签研究
期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2020-0093
Abou-Alfa, Ghassan K; Mayer, Robert; Venook, Alan P; O'Neill, Allison F; Beg, Muhammad S; LaQuaglia, Michael; Kingham, Peter T; Kobos, Rachel; Basturk, Olca; Brennan, Cameron; Yopp, Adam; Harding, James J; Leong, Stephen; Crown, John; Hoti, Emir; Leonard, Gregory; Ly, Michele; Bradley, Mikaela; Valentino, Emily; Markowitz, David; Zukiwski, Alexander; Ren, Ken; Gordan, John D